VANGUARD GROUP INC 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 2:20 pm Unchanged | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | VANGUARD GROUP INC | 6,864,137 6.830% | 0 (Unchanged) | Filing |
| 2024-11-04 10:20 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | VANGUARD GROUP INC | 6,864,137 6.830% | 6,864,137 (New Position) | Filing |